Wound and Tissue Management Market Report Suite | Europe | 2019-2025

EUROPEAN WOUND AND TISSUE MANAGEMENT MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

2.1 DISEASE TREATMENTS & DIAGNOSTICS
2.1.1 Vascular Malformations
2.1.2 Deep Ven Thrombosis and Pulmonary Embolism
2.1.3 Lower Extremity Ulcers
2.1.4 Lymphedema
2.1.5 Surgery
2.1.6 Traumas and Burns
2.2 PATIENT DEMOGRAPHICS
2.2.1 Vascular Malformations
2.2.2 Deep Vein Thrombosis and Pulmonary Embolism
2.2.3 Lower Extremity Ulcers
2.2.4 Lymphedema
2.2.5 Traumas and Burns

3.1 INTRODUCTION
3.2 PRODUCT PORTFOLIOS
3.2.1 Wound Closure Devices
3.2.1.1 Sutures
3.2.1.2 Staplers
3.2.1.3 Ligating Clip Appliers
3.2.1.4 Wound Closure Strips
3.2.1.5 Tissue Adhesives
3.2.2 Traditional Wound Dressings
3.2.3 Advanced Wound Dressings
3.2.3.1 Moist Dressings
3.2.3.1.1 Foam Dressings
3.2.3.1.2 Transparent Film Dressings
3.2.3.1.3 Hydrocolloid Dressings
3.2.3.1.4 Alginate Dressings
3.2.3.1.5 Hydrofiber Dressings
3.2.3.1.6 Hydrogel Dressings
3.2.3.2 Antimicrobial Dressings
3.2.3.2.1 Silver Dressing
3.2.3.2.2 Non-Silver Dressing
3.2.3.3 Interactive Dressing
3.2.3.3.1 Bioactive Dressings
3.2.3.3.2 Skin Substitute
3.2.3.4 Non-Adherent Contact Layer
3.2.4 Surgical Hemostats
3.2.4.1 Thrombin-Based Hemostats
3.2.4.2 Oxidized Regenerated Cellulose Hemostats
3.2.4.3 Gelatin-Based Hemostat
3.2.4.4 Collagen-Based Hemostat
3.2.4.5 Combination Hemostat
3.2.4.6 Polysaccharide-Based Hemostat
3.2.4.7 First Responder Hemostat
3.2.5 Tissue Sealants
3.2.5.1 Fibrin-Based Tissue Sealants
3.2.5.2 Albumin-Based Tissue Sealants
3.2.5.3 PEG-Based Sealants
3.2.6 Anti-Adhesion
3.2.7 Negative Pressure Wound Therapy
3.2.8 Static Compression Therapy
3.2.8.1 Compression Stockings
3.2.8.2 Anti-Embolism Stockings
3.2.8.3 Compression Bandages
3.2.8.4 Unna Boots
3.2.9 Dynamic Compression Therapy
3.2.9.1 Dynamic DVT Prevention
3.2.9.2 Pneumatic Compression
3.2.9.3 Mobile Compression
3.2.9.4 End Diastolic Pneumatic Compression
3.3 REGULATORY ISSUES AND RECALLS
3.3.1 3M
3.3.1.1 Static Compression Therapy
3.3.2 Acelity
3.3.2.1 Advanced Wound Dressing
3.3.2.2 Negative Pressure Wound Therapy
3.3.3 Baxter
3.3.3.1 Tissue Sealants
3.3.4 Cardinal Health
3.3.4.1 Traditional Wound Dressing
3.3.5 CryoLife
3.3.5.1 Tissue Sealants
3.3.6 Ethicon
3.3.6.1 Wound Closure Devices
3.3.6.2 Tissue Sealants
3.3.7 Medline
3.3.7.1 Wound Closure
3.3.7.2 Static Compression Therapy
3.3.8 Medtronic
3.3.8.1 Wound Closure
3.3.9 Smith & Nephew
3.3.9.1 Negative Pressure Wound Therapy
3.4 CLINICAL TRIALS
3.4.1 3M
3.4.1.1 Wound Closure
3.4.1.2 Static Compression Therapy
3.4.1.3 Traditional Wound Dressings
3.4.1.4 Advanced Wound Dressings
3.4.2 Acelity
3.4.2.1 Negative Pressure Wound Therapy
3.4.3 Baxter
3.4.3.1 Surgical Hemostats
3.4.3.2 Tissue Sealants
3.4.4 BSN Medical
3.4.4.1 Static Compression Therapy
3.4.5 C. R. Bard
3.4.5.1 Surgical Hemostats
3.4.5.2 Tissue Sealants
3.4.6 Cardinal Health
3.4.6.1 Dynamic Compression Therapy
3.4.6.2 Traditional Wound Dressings
3.4.6.3 Advanced Wound Dressings
3.4.7 CryoLife
3.4.7.1 Tissue Sealant
3.4.8 Ethicon
3.4.8.1 Wound Closure Devices
3.4.8.2 Surgical Hemostats
3.4.8.3 Tissue Sealants
3.4.8.4 Anti-Adhesion
3.4.9 Medline
3.4.9.1 Advanced Wound Dressings
3.4.10 Medtronic
3.4.10.1 Wound Closure Devices
3.4.11 MiMedx
3.4.11.1 Advanced Wound Dressings
3.4.12 Mölnlycke
3.4.12.1 Advanced Wound Dressings
3.4.13 Pfizer
3.4.13.1 Surgical Hemostats
3.4.14 Smith & Nephew
3.4.14.1 Static Compression Therapy
3.4.14.2 Advanced Wound Dressings
3.4.14.3 Negative Pressure Wound Therapy

4.1 INTRODUCTION
4.2 CURRENCY EXCHANGE RATE
4.3 MARKET OVERVIEW
4.4 TREND ANALYSIS BY SEGMENT
4.5 DRIVERS AND LIMITERS
4.5.1 Market Drivers
4.5.2 Market Limiters
4.6 COMPETITIVE MARKET SHARE ANALYSIS
4.7 MERGERS AND ACQUISITIONS
4.8 COMPANY PROFILES
4.8.1 3M
4.8.2 Acelity
4.8.3 Baxter
4.8.4 BSN Medical
4.8.5 C. R. Bard (Becton Dickinson)
4.8.6 Cardinal Health
4.8.7 CryoLife
4.8.8 Ethicon
4.8.9 Medline
4.8.10 Medtronic
4.8.11 MiMedx
4.8.12 Mölnlycke
4.8.13 Pfizer
4.8.14 Sanofi Genzyme
4.8.15 Smith & Nephew
4.9 SWOT ANALYSIS
4.9.1 3M
4.9.2 Acelity
4.9.3 Baxter
4.9.4 BSN Medical
4.9.5 C. R. Bard (Becton Dickinson)
4.9.6 Cardinal Health
4.9.7 CryoLife
4.9.8 Ethicon
4.9.9 Medline
4.9.10 Medtronic
4.9.11 MiMedx
4.9.12 Mölnlycke
4.9.13 Pfizer
4.9.14 Sanofi Genzyme
4.9.15 Smith & Nephew

COUNTRY PROFILES
5.1 INTRODUCTION
5.1.1 Population
5.1.2 GDP Per Capita
5.1.3 Price Index
5.2 GERMANY
5.3 FRANCE
5.4 UNITED KINGDOM
5.5 ITALY
5.6 SPAIN
5.7 BENELUX
5.8 SCANDINAVIA
5.9 AUSTRIA
5.10 SWITZERLAND
5.11 PORTUGAL

6.1 INTRODUCTION
6.1.1 Sutures
6.1.2 Staplers
6.1.3 Ligating Clip Appliers
6.1.4 Skin Closure Strips
6.1.5 Cyanoacrylate-Based Tissue Adhesives
6.2 MARKET OVERVIEW
6.3 TREND ANALYSIS BY SEGMENT
6.4 DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE MARKET SHARE ANALYSIS

7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Absorbable Suture Market
7.3.2 Total Non-Absorbable Suture Market
7.3.2.1 Polypropylene Suture Market
7.3.2.2 Polyester Suture Market
7.3.2.3 Polyamide Suture Market
7.3.2.4 Silk Suture Market
7.3.2.5 Stainless Steel Suture Market
7.4 DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE MARKET SHARE ANALYSIS

8.1 INTRODUCTION
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.3.1 Total Open Surgery Stapler Market
8.3.1.1 Open Surgery Firing Gun Market
8.3.1.2 Open Surgery Cartridge Market
8.3.2 Total Laparoscopic Stapler Market
8.3.2.1 Laparoscopic Firing Gun Market
8.3.2.2 Laparoscopic Cartridge Market
8.3.3 Skin Stapler Market
8.4 DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE MARKET SHARE ANALYSIS

9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Open Surgery Ligation Market
9.3.2 Laparoscopic Ligation Market